Mar 7, 2023
Aravax initiates Phase 2 peanut allergy clinical trials in Australia
8 March 2023, Melbourne, Australia: Aravax, a clinical stage biotechnology company developing next generation immunotherapies which are...
top of page
Developing safe, convenient, disease-modifying treatments for food allergies.
.jpg)
News
bottom of page